Rangwala Reshma

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
4
Insider Sells Sum
$60,852.14

Insider Activity of Rangwala Reshma

According to the SEC Form 4 filings, Rangwala Reshma, being in a position of

  1. EVP & Chief Medical Officer at Karyopharm Therapeutics Inc.,
    оver the last 12 months, has bought 0 shares, and sold 28425 shares for $33,436,
    over all time since 2023-04-20, has bought 0 shares, and sold 35195 shares for $60,852.

The largest sale of all time was on 2023-04-20 and amounted to 6770 shares of Karyopharm Therapeutics Inc. for $27,416.

Biography of Rangwala Reshma

No biography is available at this moment.

2024-04-22SaleKaryopharm Therapeutics Inc.
KPTI
EVP & Chief Medical Officer
6,789
0.006%
$1.17$7,943-15.35%
2024-03-01SaleKaryopharm Therapeutics Inc.
KPTI
EVP & Chief Medical Officer
5,969
0.0053%
$1.20$7,163-14.29%
2024-02-29SaleKaryopharm Therapeutics Inc.
KPTI
EVP & Chief Medical Officer
15,667
0.0143%
$1.17$18,330-12.07%
2023-04-20SaleKaryopharm Therapeutics Inc.
KPTI
EVP & Chief Medical Officer
6,770
0.0064%
$4.05$27,416-65%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.